A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients

Completed · Phase 2 · Has a placebo group

Conditions studied: Renal Anemia

In brief

This is a pilot phase II study to evaluate the safety and efficacy of AND017 in NDD-CKD patients

Key facts

Study ID

NCT05035641

Run by

Kind Pharmaceuticals LLC

People needed

113

Starts

2021-10-18

Expected to finish

2023-07-24

Last updated by the study team

2023-10-04

Who can join

Age: 20 and older, up to 74. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Amicis Research Center — Northridge, California, United States
• Clinical Site Partners — Winter Park, Florida, United States
• Northwest Louisiana Nephrology — Shreveport, Louisiana, United States
• Elite Research Center — Flint, Michigan, United States
• Metrolina Nephrology Associates — Charlotte, North Carolina, United States
• Southeast Renal Research Institute — Chattanooga, Tennessee, United States
• Clinical Advancement Center, PLLC — San Antonio, Texas, United States
• Peking University People's Hospital — Beijing, Beijing Municipality, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.